Yang, Li <br/><br/>
In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment.  [electronic resource] 

 -  Brain research  Jun 2015 
 - 1-11 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1872-6240 
<br/><br/><label>Standard No.: </label>10.1016/j.brainres.2015.03.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer--chemistry<br/>Analgesics, Opioid--chemistry<br/>Brain Edema--drug therapy<br/>Brain Infarction--drug therapy<br/>Brain Ischemia--drug therapy<br/>Cells, Cultured<br/>Enkephalin, Ala(2)-MePhe(4)-Gly(5)---chemistry<br/>Enkephalin, D-Penicillamine (2,5)---chemistry<br/>Enkephalins--chemistry<br/>Glutamic Acid--toxicity<br/>Ischemia--drug therapy<br/>Motor Activity--drug effects<br/>Neurons--drug effects<br/>Neuroprotective Agents--chemistry<br/>Receptors, Opioid, delta--agonists<br/>Receptors, Opioid, kappa--agonists<br/>Receptors, Opioid, mu--agonists<br/>Reperfusion Injury--drug therapy<br/>Severity of Illness Index<br/>Stroke--drug therapy